- Home
- NYT vs PEN Comparison
NYT vs PEN Comparison
Compare NYT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYT
- PEN
- Stock Information
- Founded
- NYT 1851
- PEN 2004
- Country
- NYT United States
- PEN United States
- Employees
- NYT N/A
- PEN N/A
- Industry
- NYT Newspapers/Magazines
- PEN Medical/Dental Instruments
- Sector
- NYT Consumer Discretionary
- PEN Health Care
- Exchange
- NYT Nasdaq
- PEN Nasdaq
- Market Cap
- NYT 9.3B
- PEN 9.7B
- IPO Year
- NYT N/A
- PEN 2015
- Fundamental
- Price
- NYT $56.99
- PEN $227.37
- Analyst Decision
- NYT Buy
- PEN Strong Buy
- Analyst Count
- NYT 6
- PEN 16
- Target Price
- NYT $60.33
- PEN $307.50
- AVG Volume (30 Days)
- NYT 1.3M
- PEN 360.3K
- Earning Date
- NYT 11-05-2025
- PEN 11-05-2025
- Dividend Yield
- NYT 1.27%
- PEN N/A
- EPS Growth
- NYT 19.25
- PEN 916.05
- EPS
- NYT 1.93
- PEN 3.74
- Revenue
- NYT $2,661,490,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- NYT $10.20
- PEN $15.52
- Revenue Next Year
- NYT $6.28
- PEN $14.20
- P/E Ratio
- NYT $29.52
- PEN $60.82
- Revenue Growth
- NYT 7.88
- PEN 12.92
- 52 Week Low
- NYT $44.83
- PEN $207.58
- 52 Week High
- NYT $62.24
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- NYT 53.34
- PEN 27.69
- Support Level
- NYT $55.93
- PEN $228.72
- Resistance Level
- NYT $57.62
- PEN $260.00
- Average True Range (ATR)
- NYT 0.95
- PEN 7.65
- MACD
- NYT 0.17
- PEN -2.58
- Stochastic Oscillator
- NYT 77.58
- PEN 5.53
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.